Saturday, May 26, 2012
Indo-Australia Biotechnology Fund
Dr S.Krishna Kumar’s proposed study on the topic titled “Locked nucleic acid modified aptamer-siRNA chimeric conjugates for improved chemo sensitivity and eradication of cancer stem cells’ has been selected for receiving financial support by the Indo-Australia Biotechnology Fund. It was reviewed in the Joint Biotechnology Committee Meeting of Indian and Australian members and recommended for financial support.Dr S Krishna Kumar heads Nano Technology and Stem Cell Research at Sankara Nethralaya.
Posted by Venkataramanan Ramasethu